Skip directly to searchSkip directly to the site navigationSkip directly to the page's main content

Health Indicator Report of Cancer Incidence - Liver and Intrahepatic Bile Duct

Primary liver cancer (cancer that starts in the liver) accounts for 2%-3% of all cancer diagnoses and deaths observed each year in the U.S. Roughly half the cases newly diagnosed each year in the U.S. occur among persons under age 60. Disease risk among males is 3-4 times higher than that in females, reflecting a gender difference in risk factors that include alcohol abuse, chronic infection with hepatitis B virus (HBV) or hepatitis C virus (HCV), exposure to aflatoxin, and obesity. HBV and HCV can be spread from person to person through sharing contaminated needles (such as in drug use) or unprotected sex. Given these major risk factors, liver cancer is considered largely preventable.

Incidence of Cancer of the Liver and Intrahepatic Bile Duct - Age-adjusted Rate per 100,000 Population by County, New Mexico 2007-2009


Notes

Data have been age-adjusted to the U.S. 2000 standard population.

Data Sources

  • Population Data Source: Geospatial and Population Studies Program, University of New Mexico. http://bber.unm.edu/bber_research_demPop.html.
  • Numerator: The New Mexico Tumor Registry, University of New Mexico Health Sciences Center, http://hsc.unm.edu/som/nmtr/.

Definition

Liver and intrahepatic bile duct cancer incidence refers to the number of persons newly diagnosed with liver and intrahepatic bile duct cancer during a specified time period. Measures include 1) the number of newly diagnosed cases of the liver and intrahepatic bile duct cancer; and 2) age-adjusted incidence rate of the liver and intrahepatic bile duct cancer (adjusted by the direct method to the 2000 US standard population. All rates are expressed per 100,000 persons. Measures are provided by sex and race/ethnicity.

Numerator

The number of liver and intrahepatic bile duct cancer cases newly diagnosed in New Mexico residents within a specified time period. The data are based on the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program incidence site recode for liver cancer (SEER Recode B 21071, 21072); ICD-O-3 codes: primary sites C220, C221; excludes histologies: 9590-9989, and 9140; Malignant cases: ICD behavior code 3.

Denominator

The estimated population of New Mexico residents within a specified time period.

Other Objectives

CDC Environmental Public Health Tracking, Nationally Consistent Data and Measures (EPHT NCDM)
Page Content Updated On 06/22/2014, Published on 06/22/2014
The information provided above is from the New Mexico Department of Health's NM-IBIS web site (http://ibis.health.state.nm.us). The information published on this website may be reproduced without permission. Please use the following citation: "Retrieved Fri, 18 January 2019 from New Mexico Department of Health, Indicator-Based Information System for Public Health Web site: http://ibis.health.state.nm.us".

Content updated: Fri, 5 Sep 2014 13:06:56 MDT